Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Crohn's disease (CD), ulcerative colitis (UC),
systemic lupus erythematosus
(
SLE
) and autoimmune polyglandular syndromes (APS) are autoimmune diseases (ADs) that may share common susceptibility pathways. We examined ribonucleo-protein, polypyrimidine tract-binding protein (PTB)-binding 2 (
RAVER2
) loci for these diseases in a cohort of 39 CD cases, 67 UC cases, 93
SLE
cases, 60 APS cases and 162 healthy control subjects of Tunisian origin. We genotyped 3 SNPs of
RAVER2
(rs2780814, rs1333739 and rs2780889) and evaluated it genetic association with each ADs, using X2-test. For each association, odds ratio (OR) and 95% CI were calculated. We show that rs2780814 is significantly associated with UC (P = 0.00016, P(corr) = 0.00048, OR = 3.66 (1.82; 7.34)). We also observed a trend of possible association to
SLE
(P = 0.023, P(corr) = 0.69, OR = 2.19 (1.1; 4.36)). None of these
RAVER2
SNPs were associated with CD and APS susceptibility. These findings establish
RAVER2
as a new UC genetic susceptibility factor and reveal a genetic heterogeneity of the associated polymorphisms and risk alleles between ADs suggesting different immunopathological roles of
RAVER2
in these diseases.
...
PMID:Association of the RAVER2 gene with increased susceptibility for ulcerative colitis. 2256 Dec 36